Format
Sort by
Items per page

Send to

Choose Destination

Best matches for ETHAMBUTOL/PD:

The rare ethambutol-induced optic neuropathy: A case-report and literature review. Song W et al. Medicine (Baltimore). (2017)

Ethambutol Is Cleared by a Contemporary High-Flux Hemodialyzer, and Drug Monitoring Ensures Safety and Therapeutic Effect. Chew R et al. Antimicrob Agents Chemother. (2017)

Exposure of Nursed Infants to Maternal Treatment with Ethambutol and Rifampicin. Partosch F et al. Basic Clin Pharmacol Toxicol. (2018)

Search results

Items: 1 to 20 of 2250

1.

Novel 4-methoxynaphthalene-N-acylhydrazones as potential for paracoccidioidomycosis and tuberculosis co-infection.

Rozada AM, Rodrigues FA, Sampiron EG, Seixas FA, Basso EA, Scodro RB, Kioshima ÉS, Gauze GF.

Future Microbiol. 2019 May;14:587-598. doi: 10.2217/fmb-2018-0357. Epub 2019 May 31.

PMID:
31148472
2.

Ethambutol-Loaded Solid Lipid Nanoparticles as Dry Powder Inhalable Formulation for Tuberculosis Therapy.

Nemati E, Mokhtarzadeh A, Panahi-Azar V, Mohammadi A, Hamishehkar H, Mesgari-Abbasi M, Ezzati Nazhad Dolatabadi J, de la Guardia M.

AAPS PharmSciTech. 2019 Feb 22;20(3):120. doi: 10.1208/s12249-019-1334-y.

PMID:
30796625
3.

Simultaneous determination of the potent anti-tuberculosis regimen-Pyrazinamide, ethambutol, protionamide, clofazimine in beagle dog plasma using LC-MS/MS method coupled with 96-well format plate.

Wu S, Lan L, Jiang J, Ding X, Ho CM, Lou Y, Fan G.

J Pharm Biomed Anal. 2019 May 10;168:44-54. doi: 10.1016/j.jpba.2019.02.006. Epub 2019 Feb 6.

4.

Association of ubiA mutations and high-level of ethambutol resistance among Mycobacterium tuberculosis Thai clinical isolates.

Tulyaprawat O, Chaiprasert A, Chongtrakool P, Suwannakarn K, Ngamskulrungroj P.

Tuberculosis (Edinb). 2019 Jan;114:42-46. doi: 10.1016/j.tube.2018.11.006. Epub 2018 Nov 19.

PMID:
30711156
5.

Conventional and molecular determination of drug resistance in Mycobacterium tuberculosis and Mycobacterium bovis isolates in cattle.

Sweetline Anne N, Ronald BSM, Senthil Kumar TMA, Thangavelu A.

Tuberculosis (Edinb). 2019 Jan;114:113-118. doi: 10.1016/j.tube.2018.12.005. Epub 2018 Dec 31.

PMID:
30711149
6.

Continuous-flow protocol for the synthesis of enantiomerically pure intermediates of anti epilepsy and anti tuberculosis active pharmaceutical ingredients.

Aguiar RM, Leão RAC, Mata A, Cantillo D, Kappe CO, Miranda LSM, de Souza ROMA.

Org Biomol Chem. 2019 Feb 6;17(6):1552-1557. doi: 10.1039/c8ob03088j.

PMID:
30693360
7.

Adverse reactions associated with long-term drug administration in Mycobacterium avium complex lung disease.

Kamii Y, Nagai H, Kawashima M, Matsuki M, Nagoshi S, Sato A, Kohno S, Ohgiya M, Ohta K.

Int J Tuberc Lung Dis. 2018 Dec 1;22(12):1505-1510. doi: 10.5588/ijtld.18.0171.

PMID:
30606324
8.
9.

Properties of Therapeutic Deep Eutectic Solvents of l-Arginine and Ethambutol for Tuberculosis Treatment.

Santos F, P S Leitão MI, C Duarte AR.

Molecules. 2018 Dec 24;24(1). pii: E55. doi: 10.3390/molecules24010055.

10.

Treatment outcomes for isoniazid-monoresistant tuberculosis in Peru, 2012-2014.

Cornejo Garcia JG, Alarcón Guizado VA, Mendoza Ticona A, Alarcon E, Heldal E, Moore DAJ.

PLoS One. 2018 Dec 4;13(12):e0206658. doi: 10.1371/journal.pone.0206658. eCollection 2018.

11.

Ethambutol targets the glutamate racemase of Mycobacterium tuberculosis-an enzyme involved in peptidoglycan biosynthesis.

Pawar A, Jha P, Konwar C, Chaudhry U, Chopra M, Saluja D.

Appl Microbiol Biotechnol. 2019 Jan;103(2):843-851. doi: 10.1007/s00253-018-9518-z. Epub 2018 Nov 19.

PMID:
30456576
12.

A new colorimetric method for rapid detection of ethambutol and streptomycin resistance in Mycobacterium tuberculosis: crystal violet decolorization assay (CVDA).

Coban AY, Akbal AU, Ceyhan I, Uzun M, Sertel Selale D, Aslan G, Delialioglu N, Ozyurt M, Bektore B, Bicmen C, Aslanturk A, Ucarman N, Albay A, Sig AK, Ozkutuk N, Surucuoglu S.

Antonie Van Leeuwenhoek. 2019 May;112(5):679-685. doi: 10.1007/s10482-018-1198-2. Epub 2018 Nov 11.

PMID:
30417212
13.

The use of optical coherence tomography for the detection of ocular toxicity by ethambutol.

Pavan Taffner BM, Mattos FB, Cunha MCD, Saraiva FP.

PLoS One. 2018 Nov 8;13(11):e0204655. doi: 10.1371/journal.pone.0204655. eCollection 2018.

14.

Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing.

CRyPTIC Consortium and the 100,000 Genomes Project, Allix-Béguec C, Arandjelovic I, Bi L, Beckert P, Bonnet M, Bradley P, Cabibbe AM, Cancino-Muñoz I, Caulfield MJ, Chaiprasert A, Cirillo DM, Clifton DA, Comas I, Crook DW, De Filippo MR, de Neeling H, Diel R, Drobniewski FA, Faksri K, Farhat MR, Fleming J, Fowler P, Fowler TA, Gao Q, Gardy J, Gascoyne-Binzi D, Gibertoni-Cruz AL, Gil-Brusola A, Golubchik T, Gonzalo X, Grandjean L, He G, Guthrie JL, Hoosdally S, Hunt M, Iqbal Z, Ismail N, Johnston J, Khanzada FM, Khor CC, Kohl TA, Kong C, Lipworth S, Liu Q, Maphalala G, Martinez E, Mathys V, Merker M, Miotto P, Mistry N, Moore DAJ, Murray M, Niemann S, Omar SV, Ong RT, Peto TEA, Posey JE, Prammananan T, Pym A, Rodrigues C, Rodrigues M, Rodwell T, Rossolini GM, Sánchez Padilla E, Schito M, Shen X, Shendure J, Sintchenko V, Sloutsky A, Smith EG, Snyder M, Soetaert K, Starks AM, Supply P, Suriyapol P, Tahseen S, Tang P, Teo YY, Thuong TNT, Thwaites G, Tortoli E, van Soolingen D, Walker AS, Walker TM, Wilcox M, Wilson DJ, Wyllie D, Yang Y, Zhang H, Zhao Y, Zhu B.

N Engl J Med. 2018 Oct 11;379(15):1403-1415. doi: 10.1056/NEJMoa1800474. Epub 2018 Sep 26.

15.

Molecular mechanism of the synergistic activity of ethambutol and isoniazid against Mycobacterium tuberculosis.

Zhu C, Liu Y, Hu L, Yang M, He ZG.

J Biol Chem. 2018 Oct 26;293(43):16741-16750. doi: 10.1074/jbc.RA118.002693. Epub 2018 Sep 5.

PMID:
30185616
16.

Development and biological evaluation of a new nanotheranostic for tuberculosis.

Helal-Neto E, Rocha Pinto S, Portilho FL, da Costa MD, Pereira JX, Nigro F, Ricci-Junior E, Candéa ALP, das Graças Muller de Oliveira Henriques M, Santos-Oliveira R.

Drug Deliv Transl Res. 2019 Feb;9(1):97-105. doi: 10.1007/s13346-018-0577-6.

PMID:
30178280
17.

Therapeutic implications of nano-encapsulated rifabutin, azithromycin & ethambutol against experimental Mycobacterium avium infection in mice.

Grewal TK, Majeed S, Sharma S.

Indian J Med Res. 2018 Jun;147(6):594-602. doi: 10.4103/ijmr.IJMR_2004_15.

18.

Characterizing the Effects of Glutathione as an Immunoadjuvant in the Treatment of Tuberculosis.

Cao R, Teskey G, Islamoglu H, Abrahem R, Munjal S, Gyurjian K, Zhong L, Venketaraman V.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01132-18. doi: 10.1128/AAC.01132-18. Print 2018 Nov.

19.

Optimized Background Regimen for Treatment of Active Tuberculosis with the Next-Generation Benzothiazinone Macozinone (PBTZ169).

Lupien A, Vocat A, Foo CS, Blattes E, Gillon JY, Makarov V, Cole ST.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e00840-18. doi: 10.1128/AAC.00840-18. Print 2018 Nov.

20.

Rapid detection of ethambutol-resistant Mycobacterium tuberculosis in clinical specimens by real-time polymerase chain reaction hybridisation probe method.

Chauhan DS, Sharma R, Parashar D, Das R, Sharma P, Singh AV, Singh PK, Katoch K, Katoch VM.

Indian J Med Microbiol. 2018 Apr-Jun;36(2):211-216. doi: 10.4103/ijmm.IJMM_14_304.

Supplemental Content

Loading ...
Support Center